A Vacancy‐Engineering Ferroelectric Nanomedicine for Cuproptosis/Apoptosis Co‐Activated Immunotherapy
Advanced Materials · 2024-07 · 36 (30)
DOI: 10.1002/adma.202403253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 11.05.2024. Verfasst von Yaqian Du und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Material Science and Chemical Engineering, Harbin En…. Hauptthemen laut MEDLINE: Apoptosis, Copper, Immunotherapy, Nanomedicine. Die Arbeit wurde bisher 132-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Low efficacy of immunotherapy due to the poor immunogenicity of most tumors and their insufficient infiltration by immune cells highlights the importance of inducing immunogenic cell death and activating immune system for achieving better treatment outcomes. Herein, ferroelectric Bi 2 CuO 4 nanoparticles with rich copper vacancies (named BCO‐V Cu ) are rationally designed and engineered for ferroelectricity‐enhanced apoptosis, cuproptosis, and the subsequently evoked immunotherapy. In this structure, the suppressed recombination of the electron–hole pairs by the vacancies and the band bending by the ferroelectric polarization lead to high catalytic activity, triggering reactive oxygen species bursts and inducing apoptosis. The cell fragments produced by apoptosis serve as antigens to activate T cells. Moreover, due to the generated charge by the ferroelectric catalysis, this nanomedicine can act as “a smart switch” to open the cell membrane, promote nanomaterial endocytosis, and shut down the Cu + outflow pathway to evoke cuproptosis, and thus a strong immune response is triggered by the reduced content of adenosine triphosphate. Ribonucleic acid transcription tests reveal the pathways related to immune response activation. Thus, this study firstly demonstrates a feasible strategy for enhancing the efficacy of immunotherapy using single ferroelectric semiconductor‐induced apoptosis and cuproptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Material Science and Chemical Engineering, Harbin Engineering University, Harbin, 150001, P. R. China.
- State Key Laboratory of Rare Earth Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, P. R. China.
- Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150001, P. R. China.
- College of Aerospace and Civil Engineering, Harbin Engineering University, Harbin, 150001, P. R. China.
ORCID-Profile: Jun Lin
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province
- Natural Science Foundation of Shandong Province
Zitieren
APA
Du, Y., Zhao, X., He, F., Gong, H., Yang, J., Wu, L., Cui, X., Gai, S., Yang, P., & Lin, J. (2024). A Vacancy‐Engineering Ferroelectric Nanomedicine for Cuproptosis/Apoptosis Co‐Activated Immunotherapy. Advanced Materials, 36(30). https://doi.org/10.1002/adma.202403253
Vancouver
Du Y, Zhao X, He F, Gong H, Yang J, Wu L, et al. A Vacancy‐Engineering Ferroelectric Nanomedicine for Cuproptosis/Apoptosis Co‐Activated Immunotherapy. Advanced Materials. 2024;36(30). doi:10.1002/adma.202403253
BibTeX
@article{Du2024,
author = {Du, Yaqian and Zhao, Xudong and He, Fei and Gong, Haijiang and Yang, Jiani and Wu, Linzhi and Cui, Xianchang and Gai, Shili and Yang, Piaoping and Lin, Jun},
title = {A Vacancy‐Engineering Ferroelectric Nanomedicine for Cuproptosis/Apoptosis Co‐Activated Immunotherapy},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {30},
doi = {10.1002/adma.202403253}
}
EUVIMED